Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-22
DOI
10.3389/fpsyt.2019.00955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
- (2019) Aboagyewaah Oppong-Damoah et al. PSYCHOPHARMACOLOGY
- The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
- (2018) Alan K Davis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
- (2018) Elisangela G. Cata-Preta et al. Frontiers in Pharmacology
- Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–2016
- (2018) Puja Seth et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
- (2018) Ana C. de Menezes Galvão et al. Frontiers in Psychiatry
- Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016
- (2018) Brian J. Piper et al. PLoS One
- Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001–2002 and 2012–2013
- (2018) Bradley T. Kerridge et al. ADDICTIVE BEHAVIORS
- A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents
- (2017) Hector Vargas-Perez et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- National Trends in and Correlates of Nonmedical Use of Prescription Stimulants, Nonmedical Use Frequency, and Use Disorders
- (2017) Beth Han et al. JOURNAL OF CLINICAL PSYCHIATRY
- The association of psychedelic use and opioid use disorders among illicit users in the United States
- (2017) Vincent D Pisano et al. JOURNAL OF PSYCHOPHARMACOLOGY
- An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
- (2017) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal
- (2017) Christina A Brezing et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Changes in US Lifetime Heroin Use and Heroin Use Disorder
- (2017) Silvia S. Martins et al. JAMA Psychiatry
- US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws
- (2017) Deborah S. Hasin et al. JAMA Psychiatry
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002–2003 and 2012–2013 National Survey on Drug Use and Health
- (2016) Ty S. Schepis et al. ADDICTIVE BEHAVIORS
- Increases in Drug and Opioid Overdose Deaths-United States, 2000-2014
- (2016) R. A. Rudd et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Association Between Cannabis and Psychosis: Epidemiologic Evidence
- (2016) Suzanne H. Gage et al. BIOLOGICAL PSYCHIATRY
- Trends and Correlates of Cannabis-involved Emergency Department Visits
- (2016) He Zhu et al. Journal of Addiction Medicine
- Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States
- (2016) Tulshi D. Saha et al. JOURNAL OF CLINICAL PSYCHIATRY
- Prescriptions, Nonmedical Use, and Emergency Department Visits Involving Prescription Stimulants
- (2016) Lian-Yu Chen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Classic hallucinogens in the treatment of addictions
- (2016) Michael P. Bogenschutz et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Alterations of consciousness and mystical-type experiences after acute LSD in humans
- (2016) Matthias E. Liechti et al. PSYCHOPHARMACOLOGY
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Recent Trends in the Prevalence of Marijuana Use and Associated Disorders in the United States
- (2016) Richard A. Grucza et al. JAMA Psychiatry
- Epidemiology ofDSM-5Drug Use Disorder
- (2016) Bridget F. Grant et al. JAMA Psychiatry
- National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
- (2015) Christopher M. Jones et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex
- (2015) Renee M. Johnson et al. DRUG AND ALCOHOL DEPENDENCE
- Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013
- (2015) Brendan Saloner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
- (2015) Tomislav Majić et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Medication-Assisted Treatment of Opioid Use Disorder
- (2015) Hilary Smith Connery HARVARD REVIEW OF PSYCHIATRY
- Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
- (2015) Deborah S. Hasin et al. JAMA Psychiatry
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
- (2014) Nora D. Volkow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
- (2012) Michael P. Bogenschutz et al. Drug Testing and Analysis
- Health status of ayahuasca users
- (2012) Paulo Cesar Ribeiro Barbosa et al. Drug Testing and Analysis
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- (2012) Teri S Krebs et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Extent of illicit drug use and dependence, and their contribution to the global burden of disease
- (2012) Louisa Degenhardt et al. LANCET
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Assessment of addiction severity among ritual users of ayahuasca
- (2010) Josep Maria Fábregas et al. DRUG AND ALCOHOL DEPENDENCE
- Delay discounting in current and former marijuana-dependent individuals.
- (2010) Matthew W. Johnson et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Contingency Management: Utility in the Treatment of Drug Abuse Disorders
- (2008) ML Stitzer et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started